[Br:1]Br.[Cl:3][C:4]1[CH:5]=[CH:6][C:7](/[CH:12]=[CH:13]\[C@@H:14]2[NH:18][C:17](=[O:19])[CH2:16][CH2:15]2)=[N:8][C:9]=1[O:10][CH3:11]>C(Cl)(Cl)(Cl)Cl>[Br:1]/[C:12](/[C:7]1[CH:6]=[CH:5][C:4]([Cl:3])=[C:9]([O:10][CH3:11])[N:8]=1)=[CH:13]\[C@@H:14]1[NH:18][C:17](=[O:19])[CH2:16][CH2:15]1Bromine (80 μL) was added to a solution of (5R)-5-[(Z)-2-(5-chloro-6-methoxypyridin-2-yl)ethenyl]pyrrolidin-2-one (200 mg) in carbon tetrachloride (2 mL) under ice-cooling, and the mixture was stirred at the same temperature (0° C.) for 15 minutes. The reaction solution was concentrated and the residue was dissolved in chloroform. 1,8-Diazabicyclo[5.4.0]undec-7-ene (238 μL) was added under ice-cooling, and the mixture was stirred at room temperature for one hour. The reaction solution was poured into water, followed by extraction with ethyl acetate. The organic layer was washed with brine, dried over anhydrous magnesium sulfate and filtered. The solvent was then evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate=1:1→0:1) to give the title compound as a colorless powder (164 mg, 62%).